Total Payments
$4,678
2024 Payments
$391.45
Companies
24
Transactions
60
Medicare Patients
4,795
Medicare Billing
$819,248
Payment Breakdown by Category
Food & Beverage$4,216 (90.1%)
Travel$462.01 (9.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,216 | 58 | 90.1% |
| Travel and Lodging | $462.01 | 2 | 9.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $938.37 | 8 | $0 (2023) |
| Glaukos Corporation | $375.94 | 3 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $363.10 | 3 | $0 (2017) |
| Aerie Pharmaceuticals, Inc. | $361.43 | 4 | $0 (2021) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $328.66 | 3 | $0 (2024) |
| Genentech USA, Inc. | $287.66 | 7 | $0 (2023) |
| NEW WORLD MEDICAL,INC. | $259.61 | 2 | $0 (2022) |
| Astellas Pharma US Inc | $223.67 | 4 | $0 (2024) |
| Genentech, Inc. | $190.28 | 2 | $0 (2022) |
| Allergan, Inc. | $148.75 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $391.45 | 6 | Astellas Pharma US Inc ($161.13) |
| 2023 | $633.21 | 8 | Alcon Vision LLC ($285.95) |
| 2022 | $569.99 | 11 | Genentech, Inc. ($190.28) |
| 2021 | $350.79 | 4 | Aerie Pharmaceuticals, Inc. ($122.85) |
| 2020 | $577.38 | 4 | Alcon Vision LLC ($445.58) |
| 2019 | $567.84 | 8 | Alcon Vision LLC ($149.86) |
| 2018 | $807.24 | 8 | Glaukos Corporation ($375.94) |
| 2017 | $780.50 | 11 | Novartis Pharmaceuticals Corporation ($363.10) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Ophthalmology | ||||||
| 07/31/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: Ophthalmology | ||||||
| 07/24/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.56 | General |
| Category: Ophthalmology | ||||||
| 05/28/2024 | RECORDATI_RARE_DISEASES_INC. | CYSTADROPS (Drug) | Food and Beverage | In-kind items and services | $89.24 | General |
| Category: OCULAR METABOLIC AGENT | ||||||
| 03/19/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: EYE CARE | ||||||
| 03/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Ophthalmology | ||||||
| 11/28/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: EYE CARE | ||||||
| 10/16/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/26/2023 | Alcon Vision LLC | Simbrinza (Drug), Rhopressa, Rocklatan | Food and Beverage | In-kind items and services | $119.04 | General |
| Category: Ophthalmology | ||||||
| 09/21/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $114.79 | General |
| Category: Ophthalmology | ||||||
| 09/18/2023 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $166.91 | General |
| Category: Ophthalmology | ||||||
| 09/05/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $62.54 | General |
| 05/31/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $108.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2022 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Streamline Surgical System, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $172.89 | General |
| Category: Ophthalmology | ||||||
| 08/03/2022 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Ophthalmology | ||||||
| 07/15/2022 | Genentech, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/15/2022 | Genentech, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $40.28 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/29/2022 | Genentech USA, Inc. | Lucentis (Biological), VABYSMO | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: Ophthalmology | ||||||
| 06/21/2022 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.89 | General |
| 06/15/2022 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $87.97 | General |
| 05/03/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/05/2022 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Ophthalmology | ||||||
| 03/01/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/15/2022 | Alcon Vision LLC | Simbrinza (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,209 | 2,824 | $697,347 | $185,903 |
| 2022 | 11 | 1,189 | 3,055 | $786,278 | $206,395 |
| 2021 | 9 | 1,223 | 3,320 | $827,012 | $223,220 |
| 2020 | 10 | 1,174 | 3,076 | $811,394 | $203,730 |
Total Patients
4,795
Total Services
12,275
Medicare Billing
$819,248
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 305 | 644 | $117,365 | $61,133 | 52.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 70 | 393 | $294,161 | $34,323 | 11.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 72 | 397 | $64,100 | $27,965 | 43.6% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 68 | 383 | $44,926 | $21,262 | 47.3% |
| 92134 | Imaging of retina | Office | 2023 | 184 | 353 | $52,774 | $11,487 | 21.8% |
| 92250 | Photography of the retina | Office | 2023 | 276 | 405 | $62,038 | $10,508 | 16.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 65 | 67 | $24,040 | $7,173 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $12,931 | $5,723 | 44.3% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 72 | 76 | $16,361 | $3,542 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 22 | $3,011 | $1,566 | 52.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 18 | 24 | $3,588 | $658.68 | 18.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 12 | 12 | $2,053 | $562.80 | 27.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 339 | 833 | $179,328 | $76,464 | 42.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 68 | 411 | $307,634 | $36,361 | 11.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 82 | 458 | $73,949 | $32,395 | 43.8% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 66 | 404 | $47,389 | $21,819 | 46.0% |
| 92134 | Imaging of retina | Office | 2022 | 175 | 351 | $52,431 | $11,589 | 22.1% |
| 92250 | Photography of the retina | Office | 2022 | 311 | 442 | $67,706 | $11,532 | 17.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 61 | 61 | $14,068 | $6,330 | 45.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 45 | 48 | $17,222 | $4,484 | 26.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 13 | 16 | $21,528 | $4,088 | 19.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 17 | 18 | $3,080 | $934.56 | 30.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 12 | 13 | $1,944 | $397.11 | 20.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 355 | 881 | $189,662 | $82,237 | 43.4% |
| 67028 | Injection of drug into eye | Office | 2021 | 66 | 446 | $333,831 | $40,551 | 12.1% |
About Dr. Glenn Prescod, M.D
Dr. Glenn Prescod, M.D is a Ophthalmology healthcare provider based in Pawtucket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336263102.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glenn Prescod, M.D has received a total of $4,678 in payments from pharmaceutical and medical device companies, with $391.45 received in 2024. These payments were reported across 60 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,216).
As a Medicare-enrolled provider, Prescod has provided services to 4,795 Medicare beneficiaries, totaling 12,275 services with total Medicare billing of $819,248. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Pawtucket, RI
- Active Since 03/19/2007
- Last Updated 05/02/2008
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336263102
Products in Payments
- DAILIES (Device) $445.58
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $375.94
- Cequa (Drug) $328.66
- Lucentis (Biological) $258.49
- rocklatan (Drug) $221.32
- ACTHAR (Biological) $204.40
- SUSVIMO (Drug) $190.28
- Simbrinza (Drug) $176.02
- Kahook Dual Blade (Device) $172.89
- Constellation (Device) $166.91
- Izervay (Drug) $161.13
- ULTRA (Device) $158.90
- Rhopressa (Drug) $140.11
- Jetrea (Drug) $132.92
- DURYSTA (Drug) $132.03
- SIMBRINZA (Biological) $128.16
- LUXTURNA (Biological) $119.26
- ILEVRO (Drug) $109.95
- EYLEA (Biological) $106.88
- CYSTADROPS (Drug) $89.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.